|

GlaxoSmithKline
Roche Pharmaceuticals
Acambis
Antigenics
Gilead Sciences
HHV-6 Foundation
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Novartis Institutes for BioMedical Research
Vical, Inc.
Viropharma
The VZV Foundation
31st Annual International Herpes Virus Workshop July 22-28, 2006 — Seattle, Washington
|